OrganoTherapeutics

SME

OrganoTherapeutics

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem. Sign in

OrganoTherapeutics

Address

Esch-sur-Alzette, Luxembourg

Contact

jens.schwamborn@organo-therapeutics.com

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem.

Matchmaking

Connect with OrganoTherapeutics

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

OrganoTherapeutics last news

15/09/2023

OrganoTherapeutics receives funding from Animal Free Research UK

Animal Free research UK is the leading medical charity in the UK that supports the replacement of the use of animals in medical research. They rely on donations and legacies to fund universities, hospitals and research organisations for the development of projects focused on the replacement of animals. Apart from […] The post OrganoTherapeutics receives funding from Animal Free Research UK first appeared on OrganoTherapeutics .

07/09/2023

OrganoTherapeutics is featured in Startup Bubble news

On September 4th, 2023, Startup Bubble news published an article featuring OrganoTherapeutics' work. Startup Bubble is a news media platform focusing on entrepreneurship, innovation and startup businesses. Founded in 2023, the platform publishes news on technology advancements and innovation from startup companies around the globe. To read the article please […] The post OrganoTherapeutics is featured in Startup Bubble news first appeared on OrganoTherapeutics .

26/07/2023

KHAN-I obtains OrganoTherapeutics shares

KHAN-I obtains OrganoTherapeutics shares – KHAN Technology Transfer Fund I (KHAN-I) have invested in OrganoTherapeutics. – The venture fund, with €70 million under management, obtained OrganoTherapeutics shares and supports the development of new therapeutics for Parkinson's disease. OrganoTherapeutics uses an innovative patient specific brain organoid model to develop novel therapeutics […] The post KHAN-I obtains OrganoTherapeutics shares first appeared on OrganoTherapeutics .